0001104659-23-101935.txt : 20230919 0001104659-23-101935.hdr.sgml : 20230919 20230919160513 ACCESSION NUMBER: 0001104659-23-101935 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230913 FILED AS OF DATE: 20230919 DATE AS OF CHANGE: 20230919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Narido Richard Clavano CENTRAL INDEX KEY: 0001956050 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38302 FILM NUMBER: 231263712 MAIL ADDRESS: STREET 1: 12 HANSEN CT CITY: MORAGA STATE: CA ZIP: 94556 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001719406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822844431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 484-254-6134 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp. DATE OF NAME CHANGE: 20171012 3 1 tm2326370-1_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2023-09-13 1 0001719406 NRX Pharmaceuticals, Inc. NRXP 0001956050 Narido Richard Clavano C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE STREET, SUITE 600 WILMINGTON DE 19801 0 1 0 0 Interim CFO s/ Richard Narido 2023-09-19